Live Online CME on Hematologic Malignancies to be presented by Johns Hopkins at Oncology Care Live Wednesday September 7th

Lymphoid Leukemia Virtual Education Summit to take place Live via Video at www.OncologyCareLive.com

The Johns Hopkins University School of Medicine today announced a complimentary online CME program which will be available live Wednesday September 7th at www.OncologyCareLive.com. The program, of special interest to hematologist and oncologists, is titled Lymphoid Leukemia Virtual Education Summit: Conversations and Controversies in Hematologic Malignancies and Hematology and is supported by an educational grant from Millennium: The Takeda Oncology Company.

Live video programming will begin at 12:30 PM EDT and conclude at 6:00 PM and will feature faculty from institutions such as the Mayo Clinic, Memorial Sloan-Kettering, Penn Presbyterian Medical Center, Roswell Park Cancer Institute, and the University of Chicago Comprehensive Cancer Center, as well as the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital.

This Continuing Medical Education (CME) program offers 4.5 AMA PRA Category 1 Credits™ and will also be available on demand at www.OncologyCareLive.com until March 7th, 2012. An additional 7.5 AMA PRA Category I Credits™ are currently available on demand at Oncology Care Live on solid tumor topics. Johns Hopkins, through its programs at Oncology Care Live, enables oncologists and other cancer care specialists to stay current on the latest diagnostic tools and treatment protocols by viewing streaming video presentations online from the convenience of any computer. There are no costs and no prerequisites.

Live programming begins Wednesday September 7th at 12:30 PM EDT with subsequent sessions beginning on the hour. Practitioners who attend live may text in questions to be addressed live online by presenting faculty, who are all respected leaders in oncology. The agenda includes:

12:30 PM EDT         The State of Cancer Care in the Coming Decade

William Nelson, MD, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University

1:00 PM                   Multiple Myeloma

                                Vincent Rajkumiar, MD, Mayo Clinic

Nilanjan Ghosh, MBBS, PhD, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital

Moderator: Carol Ann Huff, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital

2:00 PM                   CLL-- Treatment of High-Risk Disease in a Young Patient

                                Jack Goldberg, MD, Penn Presbyterian Medical Center

                                Nicole Lamanna, MD, Memorial Sloan-Kettering Cancer Center

Moderator: Douglas Gladstone, MD, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital

4:00 PM                   New Agents in NHL: Where do They Fit in the Treatment Pardigm?

                                Ron Gartenhaus, MD, University of Maryland

                                Myron Czuczman, MD, Roswell Park Cancer Institute

                                Moderator: Aaron Rapoport, MD, University of Maryland

5:00 PM                   Debate: ALL in Adolescents and Young Adults – Is It a Different Disease?

Wendy Stock, MD, University of Chicago Comprehensive Cancer Center

                                Stephen Hunger MD, University of Colorado Cancer Center

Moderator: Patrick A. Brown, MD, Johns Hopkins Children’s Center

To register to view these or other CME session, visit Oncology Care Live.

ABOUT ONCOLOGY CARE LIVE
Oncology Care Live, the world’s largest online oncology congress, is presented by the Johns Hopkins University School of Medicine and produced by PlatformQ. Oncology Care Live enables oncologists, hematology oncologists and other healthcare practitioners specializing in the diagnosis, treatment and care of cancer patients to learn, connect and interact in real time. Johns Hopkins University offers Continuing Medical Education (CME) at no cost at www. OncologyCareLive.com, providing high quality learning opportunities which feature video presentations and panel discussions and real-time interactive Q&A all from the convenience of a computer.

Oncology Care Live and PlatformQ are trademarks of PlatformQ, LLC. All other trademarks or service marks are property of their respective owners.

Each session has been approved for 1.0 AMA PRA Category 1 CreditTM.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 12 hours of Category 1 credit for completing these programs.

DATE OF RELEASE
Live sessions will be available September 7, 2011 from 12:30– 6:00 PM (EDT). These presentations will be on-demand from September 8, 2011 to March 7, 2012 at
www.OncologyCareLive.com

LEARNING OBJECTIVES

After participating in this activity, the participant will demonstrate the ability to:

  • Explain the role of newer agents in the treatment of patients with lymphoid leukemia
  • Evaluate the role of autologous transplantation in multiple myeloma in 2011
  • Formulate patient management strategies using a risk-adapted approach to the treatment of lymphoid leukemia
  • Identify optimal treatment approaches for patients with high risk multiple myeloma
  • Discuss the unique management needs of clinically important patient subgroups including those with asymptomatic, advanced, and refractory malignancies
  • Identify patient- and disease-associated factors that affect the choice of therapeutic agents
  • Discuss the state of cancer care

TARGET AUDIENCE

Hematologists, hematologists/oncologists, medical oncologists, pathologists, oncology nurses, advanced practice nurses, pharmacists, and other healthcare professionals who care for lymphoid leukemia patients.

FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES

It is the policy of the Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the course handout materials.

Conferences and events that once met in hotels and convention centers now meet live online. Why? Because live online events provide global reach, convenient online access to live video content featuring key opinion leaders, real-time networking with presenters and peers, and the efficient use of time and resources for attendees and supporters.
PlatformQ is the leading producer of live online events for audiences from 500 to 50,000. PlatformQ brings attendees, thought leaders, and product and service providers together in engaging interactive environments. PlatformQ provide marketers with measurable, targeted, and contextual environments for audience education and engagement. The result: more qualified leads, in less time, at lower cost. To learn more, visit www.PlatformQ.com.

Tags: